Dr. Graham Taylor

Biography

Professor Graham Taylor's group focuses on enhancing the diagnosis and treatment of human retroviruses and sexually transmitted infections. Their diagnostic work emphasizes the development of accessible tools to identify early disease and minimal residual disease in patients with Adult T-cell Leukaemia/Lymphoma (ATL). The group plays an important role in the MRC/Leuka study, investigating the stepwise development of malignancy in patients infected with human T-cell lymphotropic Virus type 1 (HTLV-1) to identify those at high risk for ATL and explore treatments. Affiliated with the National Centre for Human Retrovirology at Imperial College Healthcare NHS Trust, they serve as a major reference center for UK patients infected with HTLV. Their clinical research delves into ATLL treatment, pathogenesis related to HTLV-associated myelopathy (HAM), and innovative CNS imaging for HAM patients through a partnership with Imanova. The team also centers its HIV research on the management of HIV infection during pregnancy, with collaborative pharmacokinetic studies through the PANNA network. They aim to deepen the understanding of the relationship between HIV infection, treatment options, and the possibility of preterm delivery during pregnancy, including studying cervico-vaginal microbiota and their effects on outcomes for HIV-infected women. This transforms their scientific research to ensure improvements in HIV-related pregnancy outcomes as well as fetal and neonatal development.

Research Interests

Experience